| I. BL Aug. 2019 | II. 3 M Nov. 2018 | III. 6 M Feb. 2019 | IV. 9 M May 2019 | V. 12 M Aug. 2019 | VI. 15 M Nov. 2019 | VII. 18 M Feb. 2020 | Not evaluated | VIII. 24 M Aug. 2020 | IX. 27 M Nov. 2020 | ANOVA |
Group E n = 7 | 26.1 ± 3.1 | 26.3 ± 3.5 | 27.1 ± 2.2 | 26.3 ± 2.6 | 26.2 ± 2.6 | 26.9 ± 2.5 | 26.7 ± 2.1 |
| 21.1 ± 2.6 | 23.1 ± 1.9 | I > VIII* II > VIII* III > VIII* IV > VIII* V > VIII* VI > VIII* VII > VIII** |
Group F n = 15 | 25.4 ± 1.8 | 26.4 ± 2.2 | 26.2 ± 2.2 | 26.2 ± 2.1 | 26.8 ± 2.4 | 26.9 ± 0.8 | 27.9 ± 1.1 |
| 27.1 ± 1.5 | 27.8 ± 1.1 | I < VII* I < IX** |